D.R. Horton
DHI
Lennar Corp
LEN
KB Home
KBH
Petroleo Brasileiro SA Petrobras
PBR
Ecopetrol
EC
US Stock MarketDetailed Quotes
HUMA Humacyte
- 2.900
- -0.190-6.15%
Close Mar 10 16:00 ET
- 2.861
- -0.039-1.36%
Post 19:59 ET
373.14MMarket Cap-2.16P/E (TTM)
3.044High2.835Low2.19MVolume3.030Open3.090Pre Close6.35MTurnover2.29%Turnover RatioLossP/E (Static)128.67MShares9.97052wk High-5.86P/B277.26MFloat Cap2.81052wk Low--Dividend TTM95.61MShs Float17.450Historical High--Div YieldTTM6.75%Amplitude1.960Historical Low2.907Avg Price1Lot Size
About Humacyte Company
Humacyte, Inc. engages in the business of developing and manufacturing off-the-shelf, universally implantable, bioengineered human tissues, advanced tissue constructs, and organ systems with the goal of improving the lives of patients and transforming the practice of medicine. The company was founded by Laura E. Niklason, Shannon Dahl, and Juliana L. Blum on October 13, 2004 and is headquartered in Durham, NC.
Company Profile
SymbolHUMA
Company NameHumacyte
Listing DateDec 1, 2020
Founded2004
CEOMs. Laura E. Niklason
MarketNASDAQ
Employees185
Fiscal Year Ends12-31
Address2525 East North Carolina Highway 54
CityDurham
ProvinceNorth Carolina
CountryUnited States of America
Zip Code27713
Phone1-919-313-9633
Websitehttp://humacyte.com
Company Executives
- Name
- Position
- Salary
- Dr. Laura E. Niklason
- President, Chief Executive Officer and Director
- 2.63M
- Shamik J. Parikh
- Chief Medical Officer
- --
- Dale A. Sander
- Principal Accounting Officer, Chief Financial Officer, Chief Corporate Development Officer and Treasurer
- 1.35M
- Dr. Heather Prichard
- Chief Operating Officer
- 1.27M
- William John Scheessele
- Chief Commercial Officer
- --
- Dr. Yang Cao
- Chief Regulatory Officer
- --
- Kathleen Sebelius
- Chairman of the Board
- 96.76K
- Rajiv Shukla
- Director
- 71.76K
- Brady W. Dougan
- Director
- 71.76K
- Dr. Keith Anthony Jones
- Independent Director
- --
- Dr. John P. Bamforth
- Independent Director
- --
- Gordon M. Binder
- Independent Director
- 71.76K
- Diane Seimetz
- Independent Director
- 71.76K
- Todd M. Pope
- Independent Director
- 76.76K
- Michael T. Constantino
- Independent Director
- 79.26K
- Max Wallace
- Independent Director
- 76.76K
- C. Bruce Green
- Independent Director
- 71.76K
- Dr. Susan Richards Windham-Bannister, PhD
- Independent Director
- 71.76K
- Dr. Emery N. Brown
- Independent Director
- 71.76K
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.